• Journal: Kidney360
Clear all

Sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists effects on kidney and clinical outcomes in Veterans with type 2 diabetes

Abstract: Background: The primary aim of this study was to compare kidney end points between patients with type 2 diabetes (T2D) 36 months after initiation on a sodium-glucose …

US Veterans Administration autosomal dominant polycystic kidney disease cohort: Demographic, comorbidity and key laboratory data characteristics

Abstract: BACKGROUND: We used the largest integrated US health care system, the Veterans Health Administration (VHA), to establish a robust resource for demographic, longitudinal …

Kidney outcomes with sodium-glucose cotransporter-2 inhibitor initiation after acute kidney injury among Veterans with diabetic kidney disease

Abstract: BACKGROUND: The effect of SGLT2i on kidney function after acute kidney injury (AKI) is unknown. METHODS: The study population was drawn from a retrospective cohort of …